Hindawi Neural Plasticity Volume 2021, Article ID 8874296, 21 pages https://doi.org/10.1155/2021/8874296 Research Article Synergistic Network Pharmacology for Traditional Chinese Medicine Liangxue Tongyu Formula in Acute Intracerebral Hemorrhagic Stroke Yang Chen,1,2 Ju Dong,1 Dongqing Yang,1 Qin Qian,1 Pengcheng Wang,1 Xiaojuan Yang,1 Wei Li,1 Guochun Li ,1 Xu Shen ,2 and Fushun Wang 3 1Department of Public Health of Nanjing University of Chinese Medicine, 210023 Nanjing, Jiangsu Province, China 2State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, 210023 Nanjing, Jiangsu Province, China 3Institute of Brain and Psychology, Sichuan Normal University, 610060 Chengdu, Sichuan Province, China Correspondence should be addressed to Guochun Li;
[email protected], Xu Shen;
[email protected], and Fushun Wang;
[email protected] Received 12 May 2020; Revised 22 June 2020; Accepted 5 February 2021; Published 27 February 2021 Academic Editor: J. Michael Wyss Copyright © 2021 Yang Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Nowadays, acute intracerebral hemorrhage stroke (AICH) still causes higher mortality. Liangxue Tongyu Formula (LXTYF), originating from a traditional Chinese medicine (TCM) prescription, is widely used as auxiliary treatment for AICH. Objective. To dig into the multicomponent, multitarget, and multipathway mechanism of LXTYF on treating AICH via network pharmacology and RNA-seq. Methods. Network pharmacology analysis was used by ingredient collection, target exploration and prediction, network construction, and Gene Ontology (GO) and KEGG analysis, with the Cytoscape software and ClusterProfiler package in R.